Back to ARQT
MARSHALL WACE, LLP ARQT Position History
Arcutis Biotherapeutics, Inc. • Healthcare
Quarters held
17
Latest value
$8.8M
Q2 2026
Peak value
$45.3M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $25.4M |
| Q2 2023 | $22.1M |
| Q3 2023 | $12.3M |
| Q4 2023 | $56K |
| Q4 2023 | $251K |
| Q1 2025 | $906K |
| Q3 2025 | $160K |
| Q3 2025 | $185K |
| Q4 2025 | $228K |
| Q4 2025 | $1.2M |
| Q4 2025 | $11.8M |
| Q1 2026 | $215K |
| Q1 2026 | $11.8M |
| Q1 2026 | $45.3M |
| Q2 2026 | $302K |
| Q2 2026 | $2.6M |
| Q2 2026 | $8.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $8.8M | 334.5K | — | — |
| Q2 2026 | $2.6M | 100.8K | — | — |
| Q2 2026 | $302K | 11.5K | — | — |
| Q1 2026 | $45.3M | 1.92M | — | — |
| Q1 2026 | $11.8M | 501.4K | — | — |
| Q1 2026 | $215K | 9.1K | — | — |
| Q4 2025 | $11.8M | 405.9K | — | — |
| Q4 2025 | $1.2M | 40.5K | — | — |
| Q4 2025 | $228K | 7.8K | — | — |
| Q3 2025 | $185K | 9.8K | — | — |
| Q3 2025 | $160K | 8.5K | — | — |
| Q1 2025 | $906K | 57.9K | — | — |
| Q4 2023 | $251K | 77.7K | — | — |
| Q4 2023 | $56K | 17.3K | — | — |
| Q3 2023 | $12.3M | 2.31M | — | — |
| Q2 2023 | $22.1M | 2.32M | — | — |
| Q1 2023 | $25.4M | 2.31M | — | — |
Other funds holding ARQT
$152.7M
$152.7M
$148.3M
$109M
$104M
$90.1M
$81.2M